ArticleBiomaterials advances2025
Gingerol encapsulated lipid nanoparticles on 3D-printed scaffolds for orthopedic and dental applications.
Article in Biomaterials advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biofilm-Antagonist Ginger-Based 3D-Printable Photoresins for Complex Implant Designs Exhibiting Advanced Multifunctional Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Advances in 3D-Printed Drug Delivery and Screening Platforms for Bone Disease Therapy.Pharmaceutics · 2025Review
- Phytochemicals as modulators of dendritic cell functions: implications for tolerogenic cell-based therapy.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Natural medicinal compounds (NMCs) exhibit medicinal properties and show particular promise in healing bone defects caused by osteosarcoma or fractures. Gingerol (GE) sourced from ginger root (Zingiber officinale) extract, possesses antibacterial, osteogenic, analgesic, antitumorigenic, and anti-inflammatory properties. We encapsulate gingerol within lipid nanoparticles (LNPs) to promote these beneficial properties and provide enhanced stability. These GE LNPs paired with 3D-printed tricalcium phosphate allow for patient-specific drug delivery at the wound site. This system reveals a 16 % and 12 % reduction in burst release of the GE in pH 5.0 and 7.4, respectively. GE LNPs exhibit a 1.3-fold increase in osteoblast viability and 3.3-fold higher cytotoxicity towards osteosarcoma cells compared to untreated scaffolds. Treated scaffolds also show a 4.4-fold reduction in the gram-positive Staphylococcus aureus through cell wall dilation and rupture. Integrating GE LNPs into 3D-printed scaffolds reveals a novel strategy to expedite bone repair and may hold potential in future bone tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.